Literature DB >> 9191837

Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression.

A F Bell1, J B Burns, R S Fujinami.   

Abstract

Measles virus (MV) suppresses specific functions in cells of the immune system and causes a generalized immunosuppression by mechanisms which remain undefined. It has been previously established that mitogen-induced proliferation of peripheral blood mononuclear cells (PBMC) is suppressed by infection with MV. Our current study demonstrates that MV infection inhibits antigen-specific proliferation of T lymphocytes. The inhibition of proliferation was not due to a decrease in IL-2 production. IL-2 production in cultures of infected and uninfected antigen-specific T cells was similar. In contrast, we found that expression of the IL-2R alpha subunit was decreased in mitogen-stimulated, MV-infected PBMC and antigen-stimulated, MV-infected T lymphocytes compared to stimulated but noninfected T cells. However, the expression of the IL-2R beta subunit was not altered in MV-infected T cells. We also examined the influence of MV infection on the production of the cytokines IL-4, IL-6, IL-10, and IFN-gamma by T lymphocytes. By comparing infected versus uninfected antigen-specific T cell lines, we found that MV infection of antigen-specific activated T cells caused no substantial change in generation of IFN-gamma, IL-6, or IL-10. There was a 50% reduction in IL-4 generation following MV infection. These data indicate that the immunosuppression by acute MV infection is not associated with a generalized inhibition of cytokine production. One mechanism for the suppression of proliferation following acute MV infection may be a block in the expression of the IL-2R alpha subunit by activated T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191837     DOI: 10.1006/viro.1997.8577

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

Review 1.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

2.  Modulation of immune system function by measles virus infection: role of soluble factor and direct infection.

Authors:  R S Fujinami; X Sun; J M Howell; J C Jenkin; J B Burns
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 3.  DNA and RNA-based vaccines: principles, progress and prospects.

Authors:  W W Leitner; H Ying; N P Restifo
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

4.  Potential viral pathogenic mechanism for new variant inflammatory bowel disease.

Authors:  V Uhlmann; C M Martin; O Sheils; L Pilkington; I Silva; A Killalea; S B Murch; J Walker-Smith; M Thomson; A J Wakefield; J J O'Leary
Journal:  Mol Pathol       Date:  2002-04

5.  Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression.

Authors:  D Naniche; S I Reed; M B Oldstone
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 6.  Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors.

Authors:  H Van Loveren; J G Van Amsterdam; R J Vandebriel; T G Kimman; H C Rümke; P S Steerenberg; J G Vos
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

7.  Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult Patients.

Authors:  Cédric Rafat; Kada Klouche; Jean-Damien Ricard; Jonathan Messika; Antoine Roch; Sonia Machado; Romain Sonneville; Olivier Guisset; Wilfried Pujol; Claude Guérin; Jean-Louis Teboul; Natacha Mrozek; Michaël Darmon; Frank Chemouni; Matthieu Schmidt; Emmanuelle Mercier; Didier Dreyfuss; Stéphane Gaudry
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

8.  The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.

Authors:  Etai Rotem; Omri Faingold; Meital Charni; Yoel A Klug; Daniel Harari; Liraz Shmuel-Galia; Alon Nudelman; Varda Rotter; Yechiel Shai
Journal:  PLoS Pathog       Date:  2018-05-04       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.